Sirpa Laakso

507 total citations
10 papers, 333 citations indexed

About

Sirpa Laakso is a scholar working on Pharmacology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Sirpa Laakso has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Pharmaceutical Science and 3 papers in Immunology. Recurrent topics in Sirpa Laakso's work include Biosimilars and Bioanalytical Methods (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Protein purification and stability (2 papers). Sirpa Laakso is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Protein purification and stability (2 papers). Sirpa Laakso collaborates with scholars based in Finland, United Kingdom and Germany. Sirpa Laakso's co-authors include Markku Anttila, Philip Timmerman, Pirjo Kortesuo, Manja Ahola, Mika Scheinin, Antti Yli‐Urpo, Juha Kiesvaara, Lauri Vuorilehto, Tiina Leino and Martti Marvola and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Sirpa Laakso

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sirpa Laakso Finland 6 75 72 63 51 50 10 333
John Paul Fawcett China 12 153 2.0× 44 0.6× 70 1.1× 36 0.7× 66 1.3× 25 507
Karen A. Fisher United States 7 140 1.9× 79 1.1× 22 0.3× 39 0.8× 49 1.0× 10 486
Chong Su China 10 115 1.5× 35 0.5× 58 0.9× 23 0.5× 59 1.2× 14 371
Selvan Ravindran India 10 104 1.4× 75 1.0× 25 0.4× 33 0.6× 16 0.3× 40 381
Girish Bende India 10 110 1.5× 27 0.4× 40 0.6× 28 0.5× 57 1.1× 14 356
Johannes Krämer Germany 10 59 0.8× 68 0.9× 51 0.8× 24 0.5× 200 4.0× 16 350
Jennifer L. H. Johnson United States 10 54 0.7× 91 1.3× 68 1.1× 19 0.4× 75 1.5× 16 412
Abdullah A. Al‐Badr Saudi Arabia 10 77 1.0× 42 0.6× 40 0.6× 27 0.5× 54 1.1× 29 312
Katsumi Iga Japan 13 128 1.7× 37 0.5× 33 0.5× 26 0.5× 120 2.4× 42 464
Elnaz Tamizi Iran 11 130 1.7× 129 1.8× 128 2.0× 42 0.8× 29 0.6× 27 407

Countries citing papers authored by Sirpa Laakso

Since Specialization
Citations

This map shows the geographic impact of Sirpa Laakso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sirpa Laakso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sirpa Laakso more than expected).

Fields of papers citing papers by Sirpa Laakso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sirpa Laakso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sirpa Laakso. The network helps show where Sirpa Laakso may publish in the future.

Co-authorship network of co-authors of Sirpa Laakso

This figure shows the co-authorship network connecting the top 25 collaborators of Sirpa Laakso. A scholar is included among the top collaborators of Sirpa Laakso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sirpa Laakso. Sirpa Laakso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kästner, Sabine, et al.. (2024). Anaesthetic-sparing effect of the anxiolytic drug tasipimidine in Beagle dogs. Veterinary Anaesthesia and Analgesia. 51(3). 244–252. 1 indexed citations
3.
Ojala, K., Anna Shevchenko, Timo Korjamo, et al.. (2021). How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation. International Journal of Pharmaceutics. 606. 120875–120875. 4 indexed citations
4.
Wilson, Amanda, Achim Freisleben, Sirpa Laakso, et al.. (2018). European Bioanalysis Forum Recommendation on the Best Practices to Demonstrate Processed Sample Stability. Bioanalysis. 11(1). 7–11. 1 indexed citations
5.
Laakso, Sirpa, Hermann Mascher, Klaus Pusecker, et al.. (2014). Bioanalysis for Plasma Protein Binding Studies in Drug Discovery and Drug Development: Views and Recommendations of The European Bioanalysis Forum. Bioanalysis. 6(5). 673–682. 82 indexed citations
6.
Timmerman, Philip, et al.. (2010). Best Practices in a Tiered Approach to Metabolite Quantification: Views and Recommendations of The European Bioanalysis Forum. Bioanalysis. 2(7). 1185–1194. 55 indexed citations
7.
Kortesuo, Pirjo, Manja Ahola, Mika Jokinen, et al.. (2002). Effect of synthesis parameters of the sol–gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine. Biomaterials. 23(13). 2795–2801. 50 indexed citations
8.
Kortesuo, Pirjo, Manja Ahola, Tiina Leino, et al.. (2001). Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine. Journal of Controlled Release. 76(3). 227–238. 76 indexed citations
9.
Anttila, Markku, et al.. (1995). Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function. Clinical Pharmacology & Therapeutics. 57(6). 628–635. 25 indexed citations
10.
Laakso, Sirpa, Mika Scheinin, & Markku Anttila. (1990). Determination of erythromycin base and 2′-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 526(2). 475–486. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026